Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2883 results found
2025 ∙ Rahimi, H. K. Jasim, A. A. Rezahosseini, O. Harboe, Z. B.
Immunogenicity and adverse effects of pneumococcal vaccines co-administered with influenza or SARS-CoV-2 vaccines in adults: A systematic review and Meta-analysis
Adults Older adults Pneumococcal disease Influenza COVID-19 Efficacy/effectiveness Safety Administration
Rating:
Low
2025 ∙ Niyati, R. Rezahosseini, O. Ekenberg, C. Larsen, C. S. Harboe, Z. B.
Immunogenicity and Safety of Pneumococcal Vaccines Co-Administered with Common Travel Vaccines in Adults: A Systematic Review +
Adults Older adults Pneumococcal disease Efficacy/effectiveness Safety Administration
Rating:
Low
2025 ∙ Yuan, Y. Wang, T. Xia, Y. Shi, Z. He, P.
Immunogenicity and safety of the domestic and imported live-attenuated varicella vaccine in healthy Chinese populations: a systematic review and meta-analysis
Western Pacific China Newborn Children Adolescents Adults Varicella Efficacy/effectiveness Safety
Rating:
Critically low
2025 ∙ Ngamprasertchai, T. Ruenroengbun, N. Kajeekul, R.
Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Adults Older adults Pneumococcal disease Efficacy/effectiveness Safety Administration
Rating:
Low
2025 ∙ Martins, A. M. Valero Juan, L. F. Santos, M. Martins, J. P.
Immunogenicity as a Predictor of Influenza Vaccine Efficacy: A Systematic Review
Children Adolescents Adults Older adults Influenza Efficacy/effectiveness Modeling
Rating:
Critically low
2025 ∙ Ballivian, J. Parker, E. P. K. Berrueta, M. Ciapponi, A. Argento, F. Bardach, A. Brizuela, M. Castellana, N. Comande, D. Kampmann, B. Mazzoni, A. Sambade, J. M. Stegelmann, K. Xiong, X. Munoz, F. M. Stergachis, A. Buekens, P.
Immunogenicity of COVID-19 Vaccines During Pregnancy A Systematic Review and Comparison of Pregnant Versus Nonpregnant Persons
All age groups COVID-19 Efficacy/effectiveness
Rating:
Low
2025 ∙ Davis, P. Montroy, J. Warshawsky, B. Abrams, E. M. Coward, L. Killikelly, A.
Immunogenicity of pre-exposure rabies vaccination comparing number of doses and routes of administration: A systematic review and meta-analyses
All age groups Rabies Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Azam, B. Marti, M. Goel, A. Aggarwal, R.
Immunogenicity, Efficacy, and Effectiveness of Two-Dose and Shorter Schedules of Hepatitis E Vaccine: A Systematic Review
All age groups Hepatitis E Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Ul Haq, M. Z. Irfan, H. Shah, M. S. U. Sumbal, A. Mughal, S. Ashraf, S. Basaria, A. A. A. Abdullah, Chacho, M. A. Ayalew, B. D.
Immunogenicity, safety and tolerability of 15-valent pneumococcal conjugate vaccine (V114) compared to 13-valent pneumococcal conjugate vaccine (PCV-13) in healthy infants: A systematic review and meta-analysis
Newborn Pneumococcal disease Efficacy/effectiveness Safety Administration
Rating:
Low
2025 ∙ Chen, J. Yang, C. Lin, W. Cheng, X. He, H. Li, X. Yu, J.
Immunogenicity, Safety, and Protective Efficacy of Mucosal Vaccines Against Respiratory Infectious Diseases: A Systematic Review and Meta-Analysis
All age groups COVID-19 Influenza RSV (Respiratory syncytial virus) Pertussis Tuberculosis Efficacy/effectiveness Safety Administration
Rating:
Critically low
Loading...